Search results
Results from the WOW.Com Content Network
In April 2017, Neuralink announced that it was aiming to make devices to treat serious brain diseases in the short term, with the eventual goal of human enhancement, sometimes called transhumanism. [ 22 ] [ 10 ] [ 23 ] Musk said his interest in the idea partly stemmed from the concept of " neural lace " in the fictional universe in The Culture ...
Elon Reeve Musk (/ ˈ iː l ɒ n m ʌ s k /; born June 28, 1971) is a businessman known for his key roles in the space company SpaceX and the automotive company Tesla, Inc. He is also known for his ownership of X Corp. (the company that operates the social media platform X, formerly Twitter), and his role in the founding of the Boring Company, xAI, Neuralink, and OpenAI.
Neuralink, which first tested its device in monkeys and other animals, is now testing the device in humans. The company makes a brain-chip which enables paralyzed patients to control a computer ...
In 2016, Musk launched Neuralink with help from seven scientists and one engineer. Only two remain of the founding group—Musk and engineer DJ Seo. The goal of Neuralink is to develop brain ...
Domestic cats' behavioral and personality traits cannot be predicted from their coat color. Rather, these traits depend on a complex interplay between genetic and environmental factors. [31] Not all cats are attracted and intoxicated by catnip, which only affects about two thirds of them.
ACAM2000 is a vaccine developed by Acambis, which was acquired by Sanofi Pasteur in 2008, before selling the smallpox vaccine to Emergent Biosolutions in 2017. Six strains of vaccinia were isolated from 3,000 doses of Dryvax and found to exhibit significant variation in virulence.
2003 – First vaccine for Argentine hemorrhagic fever. [16] 2006 – First vaccine for human papillomavirus (which is a cause of cervical cancer) 2006 – First herpes zoster vaccine for shingles; 2011 – First vaccine for non-small-cell lung carcinoma (comprises 85% of lung cancer cases) 2012 – First vaccine for hepatitis E [17]
An mRNA vaccine is a type of vaccine that uses a copy of a molecule called messenger RNA (mRNA) to produce an immune response. [1] The vaccine delivers molecules of antigen-encoding mRNA into cells, which use the designed mRNA as a blueprint to build foreign protein that would normally be produced by a pathogen (such as a virus) or by a cancer ...